Skip to main content

Market Overview

Bionano Genomics: Q4 Earnings Insights


Shares of Bionano Genomics (NASDAQ:BNGO) rose in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share increased 82.61% year over year to ($0.04), which beat the estimate of ($0.05).

Revenue of $3,990,000 up by 43.06% from the same period last year, which beat the estimate of $3,500,000.


Bionano Genomics hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Mar 23, 2021

Time: 04:30 PM

ET Webcast URL:

Price Action

Company's 52-week high was at $15.69

52-week low: $0.25

Price action over last quarter: Up 1580.17%

Company Overview

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.


Related Articles (BNGO)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings